Risk factors for the development of pneumonia in schizophrenia patients infected with COVID-19
Not Applicable
- Conditions
- Schizophrenia patient infected with COVID-19
- Registration Number
- JPRN-UMIN000050188
- Lead Sponsor
- other
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 99
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with comorbidities of malignancy, cerebrovascular disease, cardiovascular disease, chronic kidney disease, and epilepsy
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Association between psychotropic medication (antipsychotics, benzodiazepines, mood stabilizers) taken during COVID-19 infection and development of pneumonia
- Secondary Outcome Measures
Name Time Method